Digoxin Withdrawal Worsens Clinical Status in Stable Patients with Heart Failure Receiving Optimal Contemporaneous Therapy - A Randomized Controlled Trial

Journal of Cardiac Failure

Volumn 21, Issue 9, 2015, Pages 779-781

  Hopper, Ingrid ^a,b   Skiba, Marina ^a,b   Von Lueder, Thomas G ^a,c   Watanabe, Masataka ^a,d   Funston, Robyn ^b   Tonkin, Andrew ^a   Krum, Henry ^a,b  

^a MONASH UNIVERSITY   (Australia)

^b ALFRED HEALTH   (Australia)

^c OSLO UNIVERSITY HOSPITAL   (Norway)

^d TOKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRAIN NATRIURETIC PEPTIDE; CREATININE; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; MINERALOCORTICOID ANTAGONIST; PLACEBO; CARDIOTONIC AGENT;

ADULT; CARDIAC DEPRESSION SCALE; CARDIAC RESYNCHRONIZATION THERAPY; CLINICAL ARTICLE; CLINICAL ASSESSMENT TOOL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DEFIBRILLATOR; DETERIORATION; DIGOXIN BLOOD LEVEL; DISEASE DURATION; DRUG WITHDRAWAL; ECHOCARDIOGRAPHY; ESTIMATED GLOMERULAR FILTRATION RATE; FEMALE; GLOMERULUS FILTRATION RATE; HEART EJECTION FRACTION; HEART FAILURE; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART LEFT VENTRICLE ENDSYSTOLIC VOLUME; HEART RATE; HEART SIZE; HUMAN; INFORMED CONSENT; LETTER; MALE; OPTIMAL DRUG DOSE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SHORT FORM 36; SINUS RHYTHM; SYSTOLIC BLOOD PRESSURE; DRUG EFFECTS; HEART STROKE VOLUME; MIDDLE AGED; PATHOPHYSIOLOGY; PROCEDURES; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); TREATMENT WITHDRAWAL;

CARDIOTONIC AGENTS; DIGOXIN; FEMALE; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; STROKE VOLUME; WITHHOLDING TREATMENT;

EID: 84940614549     PISSN: 10719164     EISSN: 15328414     Source Type: Journal    
DOI: 10.1016/j.cardfail.2015.07.003     Document Type: Letter

References (11)

1. C.W. Yancy, M. Jessup, B. Bozkurt, F.A. Masoudi, J. Butler, P.E. McBride, and et al. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines J Am Coll Cardiol 62 2013 e147 e239
2. M. Packer, M. Gheorghiade, J.B. Young, P.J. Costantini, K.F. Adams, R.J. Cody, and et al. Withdrawal of digoxin from patients with chronic heart failure treated with angiotensin-converting-enzyme inhibitors. RADIANCE study N Engl J Med 329 1993 1 7
3. M. Gheorghiade, J. St Clair, C. St Clair, and G.A. Beller Hemodynamic effects of intravenous digoxin in patients with severe heart failure initially treated with diuretics and vasodilators J Am Coll Cardiol 9 1987 849 857
4. H. Krum, J.T. Bigger Jr., R.L. Goldsmith, and M. Packer Effect of long-term digoxin therapy on autonomic function in patients with chronic heart failure J Am Coll Cardiol 25 1995 289 294
5. D.W. Ferguson, W.J. Berg, J.S. Sanders, P.J. Roach, J.S. Kempf, and M.G. Kienzle Sympathoinhibitory responses to digitalis glycosides in heart failure patients. Direct evidence from sympathetic neural recordings Circulation 80 1989 65 77
6. J.G.F. Cleland, and D. Cullington Digoxin: quo vadis? Circ Heart Fail 2 2009 81 85
7. V.V. Georgiopoulou, A.P. Kalogeropoulos, G. Giamouzis, S.A. Agha, M.A. Rashad, S. Waheed, and et al. Digoxin therapy does not improve outcomes in patients with advanced heart failure on contemporary medical therapy Circ Heart Fail 2 2009 90 97
8. J.V. Freeman, J. Yang, S.H. Sung, M.A. Hlatky, and A.S. Go Effectiveness and safety of digoxin among contemporary adults with incident systolic heart failure Circ Cardiovasc Qual Outcomes 6 2013 525 533
9. J. Butler, I.S. Anand, M.A. Kuskowski, T. Rector, P. Carson, and J.N. Cohn Digoxin use and heart failure outcomes: results from the Valsartan Heart Failure Trial (Val-HeFT) Congest Heart Fail 16 2010 191 195
10. A.U. Khand, A.C. Rankin, W. Martin, J. Taylor, I. Gemmell, and J.G. Cleland Carvedilol alone or in combination with digoxin for the management of atrial fibrillation in patients with heart failure? J Am Coll Cardiol 42 2003 1944 1951
11. B. Pitt, F. Zannad, W.J. Remme, R. Cody, A. Castaigne, A. Perez, and et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators N Engl J Med 341 1999 709 717